Typical rise and fall pattern of cardiac Troponin I in diagnosing non-St elevation acute coronary syndrome in patients admitted with chest pain

Authors

  • Rabel Qayum Combined Military Hospital, Malir Pakistan
  • Shagufta Yousaf Combined Military Hospital, Malir Pakistan
  • Aisha Siddique Combined Military Hospital, Malir Pakistan
  • Aisha Ayyub Combined Military Hospital, Malir Pakistan
  • Haniah Ahmad Combined Military Hospital, Malir Pakistan
  • Sadia Dawood Combined Military Hospital, Malir Pakistan

DOI:

https://doi.org/10.55629/pakjpathol.v35i4.856

Abstract

Objective: To monitor the rise and/or fall pattern of cardiac troponin l in diagnosing non-St elevation acute coronary syndrome in patients admitted with chest pain.

Material and Methods: This descriptive study was conducted at combined military hospital from May 31st 2022, to November 2nd, 2022.Patients with typical chest pain with no change or ST elevation in their ECG were monitored through cardiac troponin I (cTnI) levels at three levels of interval at 6 hours, 12 hours, and before discharge.

Result:  271 patients were included. The average age of the patients was 54.59 ± 13.60 years. Out of the 271 patients included in the study, 69 patients (25.46%) exhibited an upward trend in cardiac troponin I (cTnI) levels over time, a falling pattern of cTnI was noted in 58 patients (21.4%) patients; and a rise and/or fall pattern of cTnI  was reported in 135 patients (49.82%). These patients were treated accordingly as per the guidelines of the American Heart Association for myocardial infarction.

Conclusion: The rise and/or fall pattern of cardiac troponin I has shown significant promise in diagnosing NSTEMI ACS patients. The dynamic changes in cardiac troponin levels over time provide valuable information regarding myocardial injury and help differentiate between myocardial infarction and other causes of chest pain. The rise and/or fall of cardiac troponin I exhibits a characteristic pattern that aligns well with the pathophysiology of NSTEMIACS, allowing for a more accurate and timely diagnosis. Additionally, the serial monitoring of cardiac troponin I levels can aid in risk stratification for patients, guide treatment decisions, and improve clinical outcomes.

Keywords: Chest pain, Myocardial infarction, Troponin I, NTSEMI

References

Bahadur K, Ijaz A, Salahuddin M, Alam A. Determination of highly sensitive cardiac troponin I 99th percentile upper reference limits in a healthy Pakistani population. Pak J Med Sci. 2020;36(6):1303-7.

DOI: https://doi.org/10.12669/pjms.36.6.2328

Khan R, Akhter J, Munir U, Almas T, Ullah W. Frequency of non-ST segment elevation myocardial infarction (NSTEMI) in acute coronary syndrome with normal electrocardiogram (ECG): Insights from a cardiology hospital in Pakistan. Cureus. 2020; 12(6): e8758. DOI: https://doi.org/10.7759/cureus.8758

Layfield C, Rose J, Alford A, Snyder SR, Apple FS, Chowdhury FM, et al. Effectiveness of practices for improving the diagnostic accuracy of non-ST elevation myocardial infarction in the emergency department: A laboratory medicine best practices™ systematic review. Clin Biochem. 2015; 48(4-5): 204-12. DOI: https://doi.org/10.1016/j.clinbiochem.20 15.01.014

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, et al. Fourth universal definition of myocardial infarction. J Am Coll Cardiol. 2018; 72(18): 2231-64. DOI: https://doi.org/10.1016/j.jacc.2018.08.1 038

Collinson PO, Saenger AK, Apple FS. High sensitivity, contemporary and point-of-care cardiac troponin assays: Educational aids developed by the IFCC committee on clinical application of cardiac bio-Markers. Clin Chem Lab Med. 2019; 57(5): 623-32. DOI: https://doi.org/10.1515/cclm-2018-1211

Qadir F, Farooq S, Khan M, Hanif B, Lakhani MS. Correlation of cardiac troponin I levels (10 folds upper limit of normal) and extent of coronary artery disease in non-ST elevation myocardial infarction. J Pak Med Assoc. 2010; 60(6): 423-8. Available at: https://www.archive.jpma.org.pk/PdfDownload/2091

Neumann JT, Twerenbold R, Ojeda F, Sörensen NA, Chapman AR, Shah ASV, et al. Application of high-sensitivity troponin in suspected myocardial infarction. New Eng J Med. 2019; 380(26): 2529-40.

DOI: https://doi.org/10.1056/nejmoa1803377

van Beek D, van Zaane B, Looije M, Peelen L, van Klei W. Typical rise and fall of troponin in (peri- procedural) myocardial infarction: A systematic review. World J Cardiol. 2016; 8(3): 293-301.

DOI: https://doi.org/10.4330/wjc.v8.i3.293

Thygesen K, Alpert JS, Jaffe AS. Fourth universal definition of myocardial infarction. J Am Coll Cardiol. 2018; 72: 2231-35. DOI: https://doi.org/10.1161/CIR.0000000000000617

Jaffe AS. Chasing troponin: how low can you go if you can see the rise? J Am Coll Cardiol 2006; 48:1763- 4.

DOI: https://doi.org/10.1016/j.jacc.2006.08.0 06

Thygesen K, Mair J, Katus H. Recommend-dations for the use of cardiac troponin measurement in acute cardiac care. Eur Heart J. 2010; 31:2197-99. DOI:https://doi.org/10.1093/eurheartj/ehq251

Macrae AR, Kavsak PA, Lustig V. Assessing the requirement for the 6-hour interval between specimens in the American Heart Association Classification of Myocardial Infarction in Epidemiology and Clinical Research Studies. Clin Chem 2006; 52: 812-15. DOI:https://doi.org/10.1373/clinchem.2005.059550

Newby LK, Christenson RH, Ohman EM. Value of serial troponin T measures for early and late risk stratification in patients with acute coronary syndromes. The GUSTO-IIa Investigators. Circulation. 1998; 98:1853-9.

DOI:https://doi.org/10.1161/01.cir.98.18.1853

Thygesen K, Alpert JS, Jaffe AS, Chaitman BR, Bax JJ, Morrow DA, White HD; Executive Group on behalf of the Joint European Society of Cardiology (ESC)/ American College of Cardiology (ACC)/ American Heart Association (AHA)/ World Heart Federation (WHF) Task Force for the Universal Definition of Myocardial Infarction. Fourth Universal Definition of Myocardial Infarction. Circulation. 2018; 138(20): e618-e651.

DOI: https://doi.org/10.1161/cir.00000000000 00617

Biener M, Mueller M, Vafaie M, Jaffe AS, Widera C, Katus HA, et al. Diagnostic performance of rising, falling, or rising and falling kinetic changes of high-sensitivity cardiac troponin T in an unselected emergency department population. Eur Heart J Acute Cardiovasc Care. 2013; 2:314–22. DOI:https://doi.org/10.1177/2048872613498517

Arora S, Cavender MA, Chang PP, Qamar A, Rosamond WD, Hall ME, et al. Outcomes of decreasing versus increasing cardiac troponin in patients admitted with non-ST-segment elevation myocardial infarction: The atherosclerosis risk in communities surveillance study. Eur Heart J Acute Cardiovasc Care. 2021; 10(9): 1048-55.

DOI: https://doi.org/10.1177/2048872619842983

Starnberg K, Jepson A, Lindahl B. Revision of the troponin T release mechanism from damaged human myocardium. Clin Chem. 2014; 60: 1098–104. DOI:https://doi.org/10.1373/clinchem.2013.217943

Apple FS, Jaffe AS, Collinson P, Mockel M, Orandezoo-Llanos J, Lindhal B. IFCC educational materials on selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin Biochem. 2015; 48 (4-5): 201-3.

DOI: http://dx.doi.org/10.1016/j.clinbiochem.2014.08.021

Downloads

Published

27-12-2024

How to Cite

1.
Qayum R, Yousaf S, Siddique A, Ayyub A, Ahmad H, Dawood S. Typical rise and fall pattern of cardiac Troponin I in diagnosing non-St elevation acute coronary syndrome in patients admitted with chest pain. Pak J Pathol [Internet]. 2024 Dec. 27 [cited 2026 Nov. 17];35(4):186-91. Available from: https://www.pakjpath.com/index.php/Pak-J-Pathol/article/view/856